Patents by Inventor Jeong-Ki Min

Jeong-Ki Min has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9752190
    Abstract: The present invention relates to a composition for detecting the undifferentiated human pluripotent stem cells comprising an agent useful for measuring the level of Desmoglein 2 (Dsg 2) mRNA or the protein thereof, a kit for detecting the undifferentiated human pluripotent stem cells comprising the said composition, a method for detecting the undifferentiated human pluripotent stem cells containing the step of measuring the level of Desmoglein 2 mRNA or the protein thereof, a method for evaluating the differentiation of human pluripotent stem cells and thereafter for separating the undifferentiated human pluripotent stem cells, a method for reducing the undifferentiated status of human pluripotent stem cells by inhibiting the expression or activation of Desmoglein 2, and a monoclonal antibody binding specifically to human Desmoglein 2.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: September 5, 2017
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Jeong Ki Min, Jongjin Park, Kwang-Hee Bae, Sang Chul Lee, Yee Sook Cho
  • Publication number: 20160097096
    Abstract: The present invention relates to a composition for detecting the undifferentiated human pluripotent stem cells comprising an agent useful for measuring the level of Desmoglein 2 (Dsg 2) mRNA or the protein thereof, a kit for detecting the undifferentiated human pluripotent stem cells comprising the said composition, a method for detecting the undifferentiated human pluripotent stem cells containing the step of measuring the level of Desmoglein 2 mRNA or the protein thereof, a method for evaluating the differentiation of human pluripotent stem cells and thereafter for separating the undifferentiated human pluripotent stem cells, a method for reducing the undifferentiated status of human pluripotent stem cells by inhibiting the expression or activation of Desmoglein 2, and a monoclonal antibody binding specifically to human Desmoglein 2.
    Type: Application
    Filed: July 22, 2015
    Publication date: April 7, 2016
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Jeong Ki MIN, Jongjin PARK, Kwang-Hee BAE, Sang Chul LEE, Yee Sook CHO
  • Patent number: 8450274
    Abstract: The present invention provides DKK2 and DKK-Fc fusion protein with angiogesis promoting activity and methods of using the same.
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: May 28, 2013
    Assignee: Theragenetex Co., Ltd.
    Inventors: Young-Guen Kwon, Jeong-Ki Min
  • Patent number: 8257470
    Abstract: Disclosed is a harmful material treatment system for recovering the energy and removing the harmful material in the process of treating the gas containing the harmful material generated in the multiplex utilization facility, in the display mall, in diverse manufacturing processes and in the vehicle painting process, more particularly, to a harmful material treatment system which can recover the energy contained in the air conditioning facility or in the exhaust gas of the process with an efficiency of more than 90%, for exhausting the inside air to the outside so as to treat the contaminating material such as odor and volatile organic chemicals, and to remove the harmful material with a removal efficiency of more than 90% by adsorbing and concentrating the harmful material with a rotary-type adsorbent.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: September 4, 2012
    Assignee: Enbion Inc.
    Inventors: Hyun Jae Lee, Myeong Soo Yoon, Min Su Shin, Won Moon Jeong, Jeong Ki Min
  • Publication number: 20110293600
    Abstract: The present invention relates to an anticancer composition comprising an antitumor agent as well as a substance having inhibitory effects on the activity or expression of L1CAM; more particularly, to an anticancer composition, which comprises an anti-L1CAM antibody specific to L1CAM, serving as a substance for inhibiting the activity of L1CAM; an oligonucleotide inhibiting the generation of L1CAM, serving as a substance for inhibiting the expression of L1CAM; and a substance selected from cisplatin, gemcitabine, 5-fluorouracil and taxol, serving as an antitumor agent.
    Type: Application
    Filed: November 27, 2009
    Publication date: December 1, 2011
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Hyo Jeong Hong, Jeong Ki Min, Hyun Ho Yoon, Jung Whoi Lee
  • Patent number: 8067387
    Abstract: The present invention relates to a method for stimulating angiogenesis using by DKK2 and composition comprising the same. The DKK2 protein of the present invention showed stimulating activities of tube formation on HUVEC, promoting activity of the sprouting of arterial circle tissues and promoting activity of vascular development in the embryo of mouse. Therefore, it can be used as the therapeutics or functional health food for treating and preventing ischemic disease.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: November 29, 2011
    Assignee: Theragen Etex Co., Ltd
    Inventors: Young-Guen Kwon, Jeong-Ki Min, Chae-Ok Yun, Young-Myeong Kim
  • Publication number: 20110223184
    Abstract: The present invention provides DKK2 and DKK-Fc fusion protein with angiogesis promoting activity and methods of using the same.
    Type: Application
    Filed: April 20, 2011
    Publication date: September 15, 2011
    Inventors: Young-Guen KWON, Jeong-Ki MIN
  • Publication number: 20090282984
    Abstract: Disclosed is a harmful material treatment system for recovering the energy and removing the harmful material in the process of treating the gas containing the harmful material generated in the multiplex utilization facility, in the display mall, in diverse manufacturing processes and in the vehicle painting process, more particularly, to a harmful material treatment system which can recover the energy contained in the air conditioning facility or in the exhaust gas of the process with an efficiency of more than 90%, for exhausting the inside air to the outside so as to treat the contaminating material such as odor and volatile organic chemicals, and to remove the harmful material with a removal efficiency of more than 90% by adsorbing and concentrating the harmful material with a rotary-type adsorbent.
    Type: Application
    Filed: March 24, 2006
    Publication date: November 19, 2009
    Applicant: ENBION INC.
    Inventors: Hyun Jae Lee, Myeong Soo Yoon, Min Su Shin, Won Moon Jeong, Jeong Ki Min
  • Publication number: 20090275509
    Abstract: The present invention relates to a method for stimulating angiogenesis using by DKK2 and composition comprising the same. The DKK2 protein of the present invention showed stimulating activities of tube formation on HUVEC, promoting activity of the sprouting of arterial circle tissues and promoting activity of vascular development in the embryo of mouse. Therefore, it can be used as the therapeutics or functional health food for treating and preventing ischemic disease.
    Type: Application
    Filed: May 23, 2007
    Publication date: November 5, 2009
    Inventors: Young-Guen Kwon, Jeong-ki Min, Chae-Ok Yun, Young-Myeong Kim